Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $185.2M | $169.5M | $208.8M | $46.9M | $57.4M | |
| Gross Profit | $42.3M | $41.5M | $46.8M | $11M | $12.6M | |
| Operating Income | $10.6M | $7.9M | $12.5M | $2M | $4.2M | |
| EBITDA | $11.9M | $9.3M | $14.3M | $2.4M | $4.7M | |
| Diluted EPS | $0.44 | $0.25 | $0.39 | $0.06 | $0.13 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $28.9M | $44.3M | $50.4M | $51.5M | $59.4M | |
| Total Assets | $49.2M | $67.4M | $74.2M | $77.4M | $90.9M | |
| Current Liabilities | $5.5M | $10.1M | $9.4M | $10.8M | $11.5M | |
| Total Liabilities | $24.4M | $29.9M | $26.4M | $26.3M | $29.9M | |
| Total Equity | $24.8M | $37.4M | $47.8M | $51.1M | $61.1M | |
| Total Debt | $19.4M | $21.1M | $18.3M | $16.4M | $21.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5.8M | $8.8M | $9.9M | $3.4M | $2.4M | |
| Cash From Investing | -$870.5K | -$3.9M | -$1.6M | -$2M | -$206K | |
| Cash From Financing | -$2.6M | -$4.4M | -$1.6M | -$1M | -$625.2K | |
| Free Cash Flow | $4.2M | $4.9M | $8.3M | $1.5M | $2.2M | |
Envela Corp. engages in recycling and re-commerce services at the forefront of the circular economy. It operates through the following segments: Consumer and Commercial. The Consumer segment focuses on selling authenticated high-end luxury goods, including pre-owned and repurposed fine jewelry, diamonds, gemstones, luxury watches, and secondary market bullion. The Commercial segment provides solutions for de-manufacturing end-of-life electronic assets, reclaiming base and precious metals, and other saleable materials. The company was founded on September 16, 1965 and is headquartered in Irving, TX.
In the current month, ELA has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ELA average analyst price target in the past 3 months is $13.00.
According to analysts, the consensus estimate is that Envela Corp. share price will rise to $13.00 per share over the next 12 months.
Analysts are divided on their view about Envela Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Envela Corp. is a Sell and believe this share price will drop from its current level to $12.00.
The price target for Envela Corp. over the next 1-year time period is forecast to be $13.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Envela Corp. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
You can purchase shares of Envela Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Envela Corp. shares.
Envela Corp. was last trading at $13.08 per share. This represents the most recent stock quote for Envela Corp.. Yesterday, Envela Corp. closed at $12.98 per share.
In order to purchase Envela Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.